DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

In an era of ever-tightening healthcare budgets, market access challenges have emerged as one of the greatest barriers threatening market penetration of new therapies across the industry, and the immune and inflammatory space is no exception."

Mrs. Kravit directs, and supports, a team of therapeutically-aligned analysts who conduct extensive primary and secondary market research in the Immune and Inflammatory space.

Prior to this role, she was a principal analyst for Decision Resources Group's Central Nervous Systems and Ophthalmology division, where she provided expert insight into the commercial aspects of drug development and market sizing across Pain indications. Her project experience includes patient-based market forecasting, market opportunity assessments, early to late-stage pipeline analyses, and competitive analytics for the life-science industry.

Andrea holds a B.A. degree, summa cum laude, from Boston University.

 

Available as a speaker

Contact Us About Your Event